Conclusions: This investigation shows high accuracy for using tumor enhancement features on 1-month posttherapy MR imaging to predict residual disease after chemoembolization of HCC. (Source: Journal of Vascular and Interventional Radiology : JVIR)
View full post on MedWorm: HIPAA
Posts Tagged ‘Evaluating’
Chemoembolization Follow-up of Hepatocellular Carcinoma with MR Imaging: Usefulness of Evaluating Enhancement Features on One-month Posttherapy MR Imaging for Predicting Residual Disease
Evaluating re-identification risks with respect to the HIPAA privacy rule.
Conclusions This work illustrates that blanket protection policies, such as Safe Harbor, leave different organizations vulnerable to re-identification at different rates. It provides justification for locally performed re-identification risk estimates prior to sharing data.
PMID: 20190059 [PubMed - in process] (Source: Journal of the American Medical Informatics Association)
View full post on MedWorm: [...]